Splink, Inc.
Development of a Versatile AI Neuroimaging Technology to Optimize Dementia Diagnosis
As of December,2024
| City | Year of Establishment | Founder |
|---|---|---|
| Tokyo | 2017 | Yuki Aoyama |
| Partner VC | Latest round of Fundraising | Valuation |
|---|---|---|
| - | Series B | - |
- Contact Information: 81-3-3589-2010
- Website:Splink, Inc.
Program name
Deep-Tech Startups Support Program
Research theme
Development of a Versatile AI Neuroimaging Technology to Optimize Dementia Diagnosis
Business Plan
The goal of this project is to develop AI-powered neuroimaging technologies to optimize the implementation of disease-modifying therapies for dementia. By addressing the challenges of diagnostic complexity, missed findings, and prognosis prediction, the solution aims to support clinicians through MRI-based software as a medical device (SaMD). This will enable more accurate and personalized diagnosis and treatment for each patient, ultimately contributing to the creation of a sustainable healthcare system.
| Phase | Business Area/Field | Research Period | Research Grant Amount |
|---|---|---|---|
| PCA | Healthcare | 2024～2027FY | JPY 999 million |
Last Updated : May 22, 2025